GrowthLoop, EVERSANA Take AI Decisioning to Biopharma Marketing
New York – November 04, 2026 -- Morning email sends delivered a 13% higher weighted composite engagement score than afternoon sends in a biopharma campaign, contradicting existing predictive models, according to GrowthLoop and EVERSANA, which are expanding their Composable AI Decisioning solution into biopharmaceutical marketing.
The solution builds on GrowthLoop's composable customer data platform (CDP) and AI Studio. It uses continuous experimentation to identify which marketing actions lift healthcare professional (HCP) engagement, then feeds those findings into AI decisioning for subsequent interactions.